Variant report
Variant | nsv518817 |
---|---|
Chromosome Location | chr3:134478108-134486080 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6767950 | chr3:134478108-134478109 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs566348420 | chr3:134478193-134478194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182881127 | chr3:134478200-134478201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374932087 | chr3:134478220-134478221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529745353 | chr3:134478297-134478298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141622184 | chr3:134478327-134478328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536345333 | chr3:134478378-134478379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555795038 | chr3:134478381-134478382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6804153 | chr3:134478439-134478440 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs73861938 | chr3:134478515-134478516 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs9828197 | chr3:134478522-134478523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs16842006 | chr3:134478555-134478556 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs557983942 | chr3:134478619-134478620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540905145 | chr3:134478630-134478631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554742430 | chr3:134478641-134478642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574498485 | chr3:134478731-134478732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543942344 | chr3:134478760-134478761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563735524 | chr3:134478763-134478764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532570248 | chr3:134478780-134478781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563891620 | chr3:134478811-134478812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148357346 | chr3:134478881-134478882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs367669248 | chr3:134478900-134478901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75274791 | chr3:134478917-134478918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35026822 | chr3:134478918-134478919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77842982 | chr3:134478919-134478920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs60621239 | chr3:134478922-134478923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533279378 | chr3:134478931-134478932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546868554 | chr3:134478933-134478934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6807008 | chr3:134478970-134478971 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs548545579 | chr3:134479046-134479047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190967858 | chr3:134479101-134479102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530973738 | chr3:134479144-134479145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549481213 | chr3:134479148-134479149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111686932 | chr3:134479181-134479182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138300334 | chr3:134479190-134479191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558115891 | chr3:134479192-134479193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143882038 | chr3:134479213-134479214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565878214 | chr3:134479216-134479217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs534918049 | chr3:134479217-134479218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs16842007 | chr3:134479281-134479282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs548747768 | chr3:134479290-134479291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574587380 | chr3:134479300-134479301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182752167 | chr3:134479323-134479324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187487859 | chr3:134479349-134479350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147242700 | chr3:134479435-134479436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17695280 | chr3:134479474-134479475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs376258919 | chr3:134479529-134479530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140851318 | chr3:134479562-134479563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559695481 | chr3:134479587-134479588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144698138 | chr3:134479593-134479594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 22522925 | CNVD |
Developmental delay | 21147756 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:134477800-134478800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr3:134478800-134479200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr3:134479200-134481200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:134479400-134480400 | Enhancers | Fetal Brain Female | brain |
5 | chr3:134479600-134480400 | Enhancers | Fetal Brain Male | brain |
6 | chr3:134479600-134480400 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr3:134479600-134480600 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr3:134479800-134480600 | Enhancers | Fetal Heart | heart |
9 | chr3:134480000-134481400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr3:134480200-134480400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr3:134480200-134481200 | Enhancers | Psoas Muscle | Psoas |
12 | chr3:134480200-134481200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
13 | chr3:134480600-134481200 | Weak transcription | Fetal Muscle Leg | muscle |
14 | chr3:134481200-134481400 | Enhancers | Fetal Muscle Leg | muscle |
15 | chr3:134481200-134484400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
16 | chr3:134484400-134489800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |